GlassScriptPhysician profile
Emily Braun
NPI 1023574043
$15,446.28
in general payments reported to CMS, 2019-2025
33 companies · $2,824 in 2025
The $2,824 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,182 · 2022: $2,960 · 2023: $3,778 · 2024: $3,701 · 2025: $2,824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,863 · Consulting Fee: $1,166 · Education: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,863.44 |
| Consulting Fee | $1,165.50 |
| Education | $274.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,911.72 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,661.81 | 2021-2025 | Dupixent |
| Genzyme Corporation | $1,305.98 | 2021-2025 | |
| Lilly USA, LLC | $1,091.37 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Janssen Biotech, INC. | $883.99 | 2022-2025 | Tremfya |
| Galderma Laboratories, L.P. | $837.19 | 2021-2025 | Aklief, Nemluvio, Oracea |
| Incyte Corporation | $710.09 | 2021-2025 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $655.09 | 2021-2023 | Jublia |
| Amgen INC. | $631.26 | 2021-2025 | Otezla, Otezla |
| Leo Pharma INC. | $629.28 | 2022-2025 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $627.72 | 2022-2024 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $610.13 | 2022-2025 | |
| Pfizer INC. | $603.83 | 2021-2024 | |
| Dermavant Sciences, INC. | $488.95 | 2022-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $472.20 | 2023-2025 | Zoryve |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $436.67 | 2021-2023 | Winlevi, Absorica Ld |
| Ucb, INC. | $323.73 | 2022-2025 | Bimzelx, Cimzia |
| Medimetriks Pharmaceuticals, INC. | $250.00 | 2022 | |
| Journey Medical Corporation | $203.62 | 2022 | |
| Mayne Pharma Commercial LLC | $186.57 | 2021-2023 | |
| Biofrontera INC. | $181.70 | 2021 | |
| Almirall LLC | $164.05 | 2021-2024 | Seysara |
| Epi Health, LLC | $154.16 | 2021-2022 | |
| Sebela Pharmaceuticals INC. | $93.00 | 2021-2023 | Pramosone, Naftin |
| Verrica Pharmaceuticals INC. | $66.03 | 2024-2025 | Ycanth |
| Vyne Pharmaceuticals INC. | $64.49 | 2021 | |
| Cipher Pharmaceuticals US LLC | $40.39 | 2025 | Natroba, Spinosad |
| Sandoz INC. | $35.95 | 2021 | |
| Organon LLC | $33.69 | 2025 | Vtama |
| Botanix Sb INC | $31.04 | 2025 | Sofdra |
| Sanofi-Aventis U.S. LLC | $24.90 | 2021 | |
| Fidia Pharma USA INC. | $20.55 | 2025 | |
| Mission Pharmacal Company | $15.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Braun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.